tiprankstipranks
Trending News
More News >
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market

Compare Intensity Therapeutics, Inc. (INTS) vs. Competitors

Compare
247 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intensity Therapeutics, Inc.
$0.42
$25.11M
-0.64
-85.27%
3 Buy
0 Hold
0 Sell
Strong Buy
Biodexa Pharmaceuticals
$2.33
$1.34M
-0.03
-94.84%
Q/C Technologies
$4.92
$20.50M
-0.03
-96.44%
Salarius Pharmaceuticals
$0.66
$5.23M
-0.02
-97.30%
Scinai Immunotherapeutics
$0.78
$775.54K
-0.07
-75.74%
Oragenics
$0.94
$3.91M
-0.06
-89.37%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INTS
Intensity Therapeutics, Inc.
0.41
-2.35
-85.22%
BDRX
Biodexa Pharmaceuticals
2.24
-40.56
-94.77%
QCLS
Q/C Technologies
4.24
-111.76
-96.34%
SLRX
Salarius Pharmaceuticals
0.77
-39.58
-98.09%
SCNI
Scinai Immunotherapeutics
0.87
-2.64
-75.36%
OGEN
Oragenics
0.95
-7.51
-88.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts